Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MGT-006 in Ulcerative Colitis (ROOT)
NCT07913347Phase 2Recruiting
- Sponsor
- Metagen Therapeutics, Inc.
- Start
- Jul 2026
- Primary completion
- Mar 2028
- Countries
- 2
01
Overview
A Phase 2 trial of MGT-006 in ulcerative colitis (UC), sponsored by Metagen Therapeutics, Inc.. Started Jul 2026; status: recruiting.
02
Drugs
MGT-006
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07913347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07913347.